公司资料
Immix Biopharma 股价、新闻与催化剂
- 股票代码:
- IMMX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
10.23 USD (-1.68%)
收盘价
最后更新: 2026年10月1日
596M USD
市值
股价为何变动
最新监测到的公司动态为“Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference”。相应的收盘价反应尚未产生。
公司概览
业务概览
Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs. Its strategy centers on translating immune biology into targeted treatment options.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Immix sits in specialty biotechnology.
商业模式特征
The company depends on clinical data, platform validation, and the ability to build a differentiated cancer story.
生物医药行业定位
Immix is a catalyst-sensitive biotech name whose stock depends on early clinical progress.
未来催化剂
- Immix’s catalysts are the oncology and immunology pipeline, especially any update that shows the company can still generate a clearer clinical path. The story remains early and data-dependent.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。